Copy number of adenoviral vector genome transduced into target cells can be measured using quantitative pcr: Application to vector titration

Biochemical and Biophysical Research Communications

Volumn 417, Issue 3, 2012, Pages 945-950

  Pei, Zheng ^a   Kondo, Saki ^a   Kanegae, Yumi ^a   Saito, Izumu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Adenovirus vector; Quantitative PCR; Virus titer

Indexed keywords

ADENOVIRUS VECTOR; CRE RECOMBINASE; VIRUS DNA;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL SURFACE; CONTROLLED STUDY; DNA TRANSFECTION; EMBRYO; GENE DOSAGE; GENE PRODUCT; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; LOXP SITE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TARGET CELL; VIRUS GENOME; VIRUS TITRATION;

ADENOVIRIDAE; BASE SEQUENCE; CELL MEMBRANE; DNA, VIRAL; GENETIC VECTORS; GENOME, VIRAL; HEK293 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; TRANSDUCTION, GENETIC;

ADENOVIRIDAE;

EID: 84856019442     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.12.016     Document Type: Article

References (23)

1. Kondo S., Takata Y., Nakano M., Saito I., Kanegae Y. Activities of various FLP recombinases expressed by adenovirus vectors in mammalian cells. J. Mol. Biol. 2009, 390:221-230.
2. Graham F.L., van der Eb A.J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973, 52:456-467.
3. Precious B., Russell W.C. Growth, purification and titration of adenovirus. Virology: A Practical Approach 1985, 193-205. IRL Press, Oxford. B.M. Mahy (Ed.).
4. Kanegae Y., Makimura M., Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn. J. Med. Sci. Biol. 1994, 47:157-166.
5. Mentel R., Matthes E., Janta-Lipinski M., Wegner U. Fluorescent focus reduction assay for the screening of antiadenoviral agents. J. Virol. Methods 1996, 59:99-104.
6. Philipson L. Adenovirus assay by the fluorescent cell-counting procedure. Virology 1961, 15:263-268.
7. Bewig B., Schmidt W.E. Accelerated titering of adenoviruses. Biotechniques 2000, 28:870-873.
8. Mittereder N., March K.L., Trapnell B.C. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 1996, 70:7498-7509.
9. Ma L., Bluyssen H.A., De Raeymaeker M., Laurysens V., van der Beek N., Pavliska H., van Zonneveld A.J., Tomme P., van Es H.H. Rapid determination of adenoviral vector titers by quantitative real-time PCR. J. Virol. Methods 2001, 93:181-188.
10. Crettaz J., Olague C., Vales A., Aurrekoetxea I., Berraondo P., Otano I., Kochanek S., Prieto J., Gonzalez-Aseguinolaza G. Characterization of high-capacity adenovirus production by the quantitative real-time polymerase chain reaction: a comparative study of different titration methods. J. Gene Med. 2008, 10:1092-1101.
11. Puntel M., Curtin J.F., Zirger J.M., Muhammad A.K., Xiong W., Liu C., Hu J., Kroeger K.M., Czer P., Sciascia S., Mondkar S., Lowenstein P.R., Castro M.G. Quantification of high-capacity helper-dependent adenoviral vector genomes in vitro and in vivo, using quantitative TaqMan real-time polymerase chain reaction. Hum. Gene Ther. 2006, 17:531-544.
12. Kreppel F., Biermann V., Kochanek S., Schiedner G. A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparations. Hum. Gene Ther. 2002, 13:1151-1156.
13. Sandig V., Youil R., Bett A.J., Franlin L.L., Oshima M., Maione D., Wang F., Metzker M.L., Savino R., Caskey C.T. Optimization of the helper-dependent adenovirus system for production and potency in vivo. Proc. Natl. Acad. Sci. USA 2000, 97:1002-1007.
14. Graham F.L., Smiley J., Russell W.C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 1977, 36:59-74.
15. Kanegae Y., Lee G., Sato Y., Tanaka M., Nakai M., Sakaki T., Sugano S., Saito I. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res. 1995, 23:3816-3821.
16. Kanegae Y., Terashima M., Kondo S., Fukuda H., Maekawa A., Pei Z., Saito I. High-level expression by tissue/cancer-specific promoter with strict specificity using a single-adenoviral vector. Nucleic Acids Res. 2010, 39:e7.
17. Miyake S., Makimura M., Kanegae Y., Harada S., Sato Y., Takamori K., Tokuda C., Saito I. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. USA 1996, 93:1320-1324.
18. Saito I., Oya Y., Yamamoto K., Yuasa T., Shimojo H. Construction of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome. J. Virol. 1985, 54:711-719.
19. Saito I., Groves R., Giulotto E., Rolfe M., Stark G.R. Evolution and stability of chromosomal DNA coamplified with the CAD gene. Mol. Cell Biol. 1989, 9:2445-2452.
20. Sambrook J., Russell D.W. Molecular Cloning 2001, Cold Spring Harbor Laboratory Press, New York. third ed.
21. Nakano M., Odaka K., Takahashi Y., Ishimura M., Saito I., Kanegae Y. Production of viral vectors using recombinase-mediated cassette exchange. Nucleic Acids Res. 2005, 33:e76.
22. Fukuda H., Terashima M., Koshikawa M., Kanegae Y., Saito I. Possible mechanism of adenovirus generation from a cloned viral genome tagged with nucleotides at its ends. Microbiol. Immunol. 2006, 50:643-654.
23. Huchins B., Sajjadi N., Seaver S., Shepherd A., Bauer S.R., Simek S., Carson K., Aguilar-Cordova E. Working toward an adenoviral vector testing standard. Mol. Ther. 2000, 2:532-534.